Overview

Effect of 6R-BH4 Treatment in Coronary Artery Disease (OXBIO Study)

Status:
Unknown status
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effect of 6R-BH4 on vascular function in patients with coronary artery disease. We hypothesize that 6R-BH4 will improve vascular function in these patients.
Phase:
Phase 2
Details
Lead Sponsor:
University of Oxford
Collaborator:
BioMarin Pharmaceutical